Insider trade

Director sold ~$7.5K of ELV shares in the open market

Traded Mar 12, 2026 · Filed Mar 23, 2026

Elevance HealthELV

~$7.5K
Reported value · 26 sh @ $287.50: 218
Holds after · shares reported: +32.6%
stock since the trade · S&P 500 +14.7%, $287.89 → $381.67 on Oct 1

Why it stands out

A board member of Elevance Health sold $7.5K of Elevance Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 12, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 23, 2026

Director<$25K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$7,475

Shares × reported transaction price

Timing vs results

43 days after results of Jan 28, 2026, 41 days before results of Apr 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $287.89 on Mar 12, 2026, within 5% of its 52-week low, after a 16% drop over the previous 30 trading days

52-week range $274.66 (Aug 1, 2025) to $452.69 (Apr 3, 2025), 7% of the way up, from 251 adjusted closes. 30 trading days earlier: $341.85 on Jan 28, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.

MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	+0.8%	-0.4%	+1.3%
30 days	+19.3%	+8.5%	+10.8%
90 days	+36.0%	+14.0%	+22.0%
180 days	+41.0%	+18.4%	+22.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0001438226-26-000007
Filed / recorded: Mar 23, 2026, 8:10 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Elevance Health, Inc.
Issuer CIK: 1156039
Ticker: ELV
Reporting person: Amy W Schulman
Relationship: Director
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Mar 12, 2026
Transaction code: S
Shares / units: 26
Price per share: $287.50
Acquired / disposed: Disposed (D)
Shares owned after: 218
Ownership form: Direct
Amendment: No

Around the same time

Officer sold7mo ago

~$911KReported value · 3,196 sh @ $284.92

Elevance Health's & President, Commercial sold $911K of Elevance Health shares. Nobody planned it ahead of time.

Why it stands out Official record

Director bought7mo ago

~$870KReported value · 3,000 sh @ $289.84

A board member of Elevance Health spent $870K of their very own money to buy Elevance Health shares. Their pile of Elevance Health shares grew by 470%.

Why it stands out Official record

7mo ago

131Shares · @ $294.07

Routine share withholding; mechanical by default.

Why it stands out Official record